| Ab01690-45.1
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.7-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-23.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-49.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-49.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-200.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-16.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-21.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-23.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.3
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-48.1
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-44.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-15.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-45.1-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-15.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-48.1-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-3.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-11.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-1.7-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-12.1
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-200.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-21.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-12.1-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-47.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-47.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-44.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-3.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-16.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.7
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-3.3-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-1.7
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-3.3
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.6
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.3-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-10.6-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-1.6-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01690-1.6
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| orb1715825
| Anti-SARS-CoV-2 Nucleoprotein Azide Free Clone CR3018
| 200µg/200µl
| Biorbyt
|
| Clonality.MO
| Mouse
|
| Request Quotation
| Request
|
| orb1671557
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgM
| 0.05 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| orb1671556
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgA1
| 0.05 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| orb1671555
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Rabbit IgG
| 0.2 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| orb1671558
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgG1
| 0.2 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| LS-C829881
| Recombinant Monoclonal Human anti-Coronavirus SARS-CoV + CoV-2 Nucleoprotein Antibody (clone CR3018 (03-018), IF) LS-C829881
| 0.2 mg
| LSBio
|
|
|
|
| Request Quotation
| Request
|
| LS-C829882
| Recombinant Monoclonal Rabbit anti-Coronavirus SARS-CoV + CoV-2 Nucleoprotein Antibody (clone CR3018 (03-018), IF) LS-C829882
| 0.2 mg
| LSBio
|
|
|
|
| Request Quotation
| Request
|
| 24-825
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgG1
| 0.2 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|
| 24-828
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Rabbit IgG
| 0.2 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|
| 24-827
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgA1
| 0.05 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|
| 24-826
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3018 (03-018)], Human IgM
| 0.05 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|